Red Yeast Rice
Natural health product licensed in Canada
- Licence holder
- Wing Quon NHP Production Inc.
- NPN or DIN-HM
- 80089909
- Status
- Active licence
- Licence date
- 3 January 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crataegus laevigata Source : New material Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 52 mg | 13 mg | Not calculated |
| Oryza sativa fermenté avec Monascus pilosus Source : Monascus pilosus - Whole Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 52 mg | 13 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Huile de fève de soja, Gélatine, Cire d'abeille, Lécithine, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
(Traditionally) used in herbal Medicine to help maintain and/or support cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use product during pregnancy and breastfeeding. Do not use if you have soy allergy. If you plan to become pregnant, do not use. If you are taking health products that affect blood coagulation or have a bleeding disorder, do not use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood thinners or protease inhibitors. Keep out of reach of children. Do not use if you have liver or kidney disease or have received an organ transplant. If you are taking other medications, consult a health care practitioner prior to use. If you have cardiovascular disorder, consult a health care practitioner. If symptoms persist or worsen, or if you develop new symptoms such as muscle pain, tenderness and/or weakness, rash or gastrointestinal discomfort, discontinue use and consult a health care practitioner. Stop using this product 7 days before any scheduled surgery or immediately if you have unscheduled surgery or if you suffer from an injury resulting in bruising or bleeding. Heartburn has been known to occur. Consult a health care practitioner prior to use if you are taking cardiac glycosides such as digitalis/digoxin, or blood pressure medication.
Source
Official Health Canada record, licence 80089909
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.